More importantly, these IL-22-mediated biological processes are associated with host defense, intestinal inflammation, metabolic disorders (obesity, diabetes, or nephropathy), tumorigenesis, and even anti-TNF therapy for IBD (10–16). Here, IL22 is linked to inflammatory bowel disease.